Tag: MIVI
Mivi Neuroscience presents primary endpoint results from EvaQ trial
Mivi Neuroscience has announced the primary endpoint results of its EvaQ trial—a prospective, multicentre, global, single-arm, US Food and Drug Administration (FDA)-regulated investigational device...
MIVI completes enrolment for study of Q revascularisation system in acute...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...
MIVI Neuroscience names Waleed Brinjikji as new medical director
Next-generation neurointerventional medical device innovator MIVI Neuroscience has announced that Waleed Brinjikji (Mayo Clinic, Rochester, USA) has joined the company as its medical director.
“The...
MIVI Neuroscience receives IDE approval to study the Q aspiration catheter
MIVI Neuroscience has announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the initiation of a...
First-in-man series of the DAISe clot management system intiated
MIVI Neuroscience has announced that it has successfully achieved first-in-man usage of the DAISe Clot Management System for next generation treatment of ischaemic stroke.
The...
